nodes	percent_of_prediction	percent_of_DWPC	metapath
Primidone—CYP2C8—Tazarotene—psoriasis	0.0914	0.122	CbGbCtD
Primidone—CYP1A2—Clobetasol propionate—psoriasis	0.0868	0.116	CbGbCtD
Primidone—CYP2B6—Cholecalciferol—psoriasis	0.0515	0.0688	CbGbCtD
Primidone—CYP1A2—Methoxsalen—psoriasis	0.0456	0.0609	CbGbCtD
Primidone—CYP2C8—Cholecalciferol—psoriasis	0.039	0.0521	CbGbCtD
Primidone—CYP2C8—Mycophenolate mofetil—psoriasis	0.0338	0.0452	CbGbCtD
Primidone—CYP2C19—Cholecalciferol—psoriasis	0.0327	0.0437	CbGbCtD
Primidone—CYP3A4—Calcitriol—psoriasis	0.0307	0.041	CbGbCtD
Primidone—CYP2C9—Cholecalciferol—psoriasis	0.0272	0.0364	CbGbCtD
Primidone—CYP2C8—Hydrocortisone—psoriasis	0.0271	0.0363	CbGbCtD
Primidone—CYP2C8—Cyclosporine—psoriasis	0.0256	0.0342	CbGbCtD
Primidone—CYP3A4—Methoxsalen—psoriasis	0.0239	0.0319	CbGbCtD
Primidone—CYP2C19—Prednisone—psoriasis	0.0227	0.0303	CbGbCtD
Primidone—CYP2B6—Dexamethasone—psoriasis	0.0223	0.0298	CbGbCtD
Primidone—CYP2C19—Cyclosporine—psoriasis	0.0215	0.0287	CbGbCtD
Primidone—CYP2C9—Cyclosporine—psoriasis	0.0179	0.0239	CbGbCtD
Primidone—CYP2C8—Dexamethasone—psoriasis	0.0169	0.0226	CbGbCtD
Primidone—CYP3A4—Cholecalciferol—psoriasis	0.0158	0.0211	CbGbCtD
Primidone—CYP2C19—Dexamethasone—psoriasis	0.0142	0.0189	CbGbCtD
Primidone—CYP3A4—Mycophenolate mofetil—psoriasis	0.0137	0.0183	CbGbCtD
Primidone—CYP3A4—Triamcinolone—psoriasis	0.0137	0.0183	CbGbCtD
Primidone—CYP2C9—Dexamethasone—psoriasis	0.0118	0.0157	CbGbCtD
Primidone—CYP3A4—Betamethasone—psoriasis	0.0118	0.0157	CbGbCtD
Primidone—CYP3A4—Prednisolone—psoriasis	0.0116	0.0155	CbGbCtD
Primidone—CYP3A4—Hydrocortisone—psoriasis	0.011	0.0147	CbGbCtD
Primidone—CYP3A4—Prednisone—psoriasis	0.011	0.0147	CbGbCtD
Primidone—CYP3A4—Cyclosporine—psoriasis	0.0104	0.0139	CbGbCtD
Primidone—CYP3A4—Dexamethasone—psoriasis	0.00684	0.00915	CbGbCtD
Primidone—Decreased appetite—Calcitriol—psoriasis	0.000752	0.00306	CcSEcCtD
Primidone—Skin disorder—Acitretin—psoriasis	0.000748	0.00304	CcSEcCtD
Primidone—Agranulocytosis—Mycophenolic acid—psoriasis	0.000741	0.00301	CcSEcCtD
Primidone—Nausea—Beclomethasone—psoriasis	0.000737	0.003	CcSEcCtD
Primidone—Anorexia—Acitretin—psoriasis	0.000734	0.00299	CcSEcCtD
Primidone—Psychotic disorder—Hydrocortisone—psoriasis	0.000723	0.00294	CcSEcCtD
Primidone—Musculoskeletal discomfort—Acitretin—psoriasis	0.000701	0.00285	CcSEcCtD
Primidone—Connective tissue disorder—Mycophenolic acid—psoriasis	0.0007	0.00285	CcSEcCtD
Primidone—Musculoskeletal discomfort—Fluocinolone Acetonide—psoriasis	0.000699	0.00285	CcSEcCtD
Primidone—Visual impairment—Mycophenolic acid—psoriasis	0.000687	0.00279	CcSEcCtD
Primidone—Anaemia—Hydroxyurea—psoriasis	0.000684	0.00279	CcSEcCtD
Primidone—Somnolence—Acitretin—psoriasis	0.000684	0.00278	CcSEcCtD
Primidone—Decreased appetite—Acitretin—psoriasis	0.000669	0.00272	CcSEcCtD
Primidone—Visual disturbance—Dexamethasone—psoriasis	0.000668	0.00272	CcSEcCtD
Primidone—Visual disturbance—Betamethasone—psoriasis	0.000668	0.00272	CcSEcCtD
Primidone—Eye disorder—Mycophenolic acid—psoriasis	0.000666	0.00271	CcSEcCtD
Primidone—Gastrointestinal disorder—Acitretin—psoriasis	0.000665	0.0027	CcSEcCtD
Primidone—Fatigue—Acitretin—psoriasis	0.000664	0.0027	CcSEcCtD
Primidone—Gastrointestinal disorder—Fluocinolone Acetonide—psoriasis	0.000663	0.0027	CcSEcCtD
Primidone—Dizziness—Methoxsalen—psoriasis	0.000642	0.00261	CcSEcCtD
Primidone—Depression—Cyclosporine—psoriasis	0.00064	0.00261	CcSEcCtD
Primidone—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—psoriasis	0.000626	0.00255	CcSEcCtD
Primidone—Depression—Mycophenolate mofetil—psoriasis	0.000624	0.00254	CcSEcCtD
Primidone—Mental disorder—Mycophenolic acid—psoriasis	0.000624	0.00254	CcSEcCtD
Primidone—Asthenia—Calcitriol—psoriasis	0.000621	0.00253	CcSEcCtD
Primidone—Malnutrition—Mycophenolic acid—psoriasis	0.00062	0.00252	CcSEcCtD
Primidone—Psychotic disorder—Betamethasone—psoriasis	0.000618	0.00251	CcSEcCtD
Primidone—Psychotic disorder—Dexamethasone—psoriasis	0.000618	0.00251	CcSEcCtD
Primidone—Rash—Methoxsalen—psoriasis	0.000612	0.00249	CcSEcCtD
Primidone—Dermatitis—Methoxsalen—psoriasis	0.000612	0.00249	CcSEcCtD
Primidone—Headache—Methoxsalen—psoriasis	0.000608	0.00248	CcSEcCtD
Primidone—Nervous system disorder—Hydroxyurea—psoriasis	0.000593	0.00241	CcSEcCtD
Primidone—Skin disorder—Hydroxyurea—psoriasis	0.000587	0.00239	CcSEcCtD
Primidone—Agranulocytosis—Mycophenolate mofetil—psoriasis	0.000584	0.00238	CcSEcCtD
Primidone—Nausea—Methoxsalen—psoriasis	0.000577	0.00235	CcSEcCtD
Primidone—Anorexia—Hydroxyurea—psoriasis	0.000576	0.00234	CcSEcCtD
Primidone—Anaemia—Mycophenolic acid—psoriasis	0.000573	0.00233	CcSEcCtD
Primidone—Connective tissue disorder—Cyclosporine—psoriasis	0.000566	0.00231	CcSEcCtD
Primidone—Vertigo—Mycophenolic acid—psoriasis	0.000557	0.00227	CcSEcCtD
Primidone—Visual impairment—Cyclosporine—psoriasis	0.000555	0.00226	CcSEcCtD
Primidone—Connective tissue disorder—Mycophenolate mofetil—psoriasis	0.000552	0.00225	CcSEcCtD
Primidone—Asthenia—Acitretin—psoriasis	0.000552	0.00225	CcSEcCtD
Primidone—Vomiting—Calcitriol—psoriasis	0.00055	0.00224	CcSEcCtD
Primidone—Rash—Calcitriol—psoriasis	0.000546	0.00222	CcSEcCtD
Primidone—Dermatitis—Calcitriol—psoriasis	0.000545	0.00222	CcSEcCtD
Primidone—Headache—Calcitriol—psoriasis	0.000542	0.00221	CcSEcCtD
Primidone—Visual impairment—Mycophenolate mofetil—psoriasis	0.000542	0.00221	CcSEcCtD
Primidone—Psychotic disorder—Prednisone—psoriasis	0.000538	0.00219	CcSEcCtD
Primidone—Somnolence—Hydroxyurea—psoriasis	0.000537	0.00219	CcSEcCtD
Primidone—Arthralgia—Mycophenolic acid—psoriasis	0.000528	0.00215	CcSEcCtD
Primidone—Eye disorder—Mycophenolate mofetil—psoriasis	0.000525	0.00214	CcSEcCtD
Primidone—Decreased appetite—Hydroxyurea—psoriasis	0.000525	0.00214	CcSEcCtD
Primidone—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—psoriasis	0.000524	0.00213	CcSEcCtD
Primidone—Gastrointestinal disorder—Hydroxyurea—psoriasis	0.000522	0.00212	CcSEcCtD
Primidone—Fatigue—Hydroxyurea—psoriasis	0.000521	0.00212	CcSEcCtD
Primidone—Nausea—Calcitriol—psoriasis	0.000514	0.00209	CcSEcCtD
Primidone—Dizziness—Acitretin—psoriasis	0.000509	0.00207	CcSEcCtD
Primidone—Dizziness—Fluocinolone Acetonide—psoriasis	0.000508	0.00207	CcSEcCtD
Primidone—Visual impairment—Prednisolone—psoriasis	0.000505	0.00206	CcSEcCtD
Primidone—Mental disorder—Cyclosporine—psoriasis	0.000505	0.00206	CcSEcCtD
Primidone—Connective tissue disorder—Hydrocortisone—psoriasis	0.000503	0.00205	CcSEcCtD
Primidone—Malnutrition—Cyclosporine—psoriasis	0.000502	0.00204	CcSEcCtD
Primidone—Nervous system disorder—Mycophenolic acid—psoriasis	0.000496	0.00202	CcSEcCtD
Primidone—Mental disorder—Mycophenolate mofetil—psoriasis	0.000493	0.002	CcSEcCtD
Primidone—Skin disorder—Mycophenolic acid—psoriasis	0.000492	0.002	CcSEcCtD
Primidone—Malnutrition—Mycophenolate mofetil—psoriasis	0.000489	0.00199	CcSEcCtD
Primidone—Vomiting—Acitretin—psoriasis	0.000489	0.00199	CcSEcCtD
Primidone—Vomiting—Fluocinolone Acetonide—psoriasis	0.000488	0.00199	CcSEcCtD
Primidone—Visual disturbance—Methotrexate—psoriasis	0.000486	0.00198	CcSEcCtD
Primidone—Rash—Acitretin—psoriasis	0.000485	0.00198	CcSEcCtD
Primidone—Dermatitis—Acitretin—psoriasis	0.000485	0.00197	CcSEcCtD
Primidone—Rash—Fluocinolone Acetonide—psoriasis	0.000484	0.00197	CcSEcCtD
Primidone—Dermatitis—Fluocinolone Acetonide—psoriasis	0.000484	0.00197	CcSEcCtD
Primidone—Anorexia—Mycophenolic acid—psoriasis	0.000482	0.00196	CcSEcCtD
Primidone—Headache—Acitretin—psoriasis	0.000482	0.00196	CcSEcCtD
Primidone—Headache—Fluocinolone Acetonide—psoriasis	0.000481	0.00196	CcSEcCtD
Primidone—Eye disorder—Hydrocortisone—psoriasis	0.000479	0.00195	CcSEcCtD
Primidone—Anaemia—Cyclosporine—psoriasis	0.000464	0.00189	CcSEcCtD
Primidone—Musculoskeletal discomfort—Mycophenolic acid—psoriasis	0.000461	0.00188	CcSEcCtD
Primidone—Nausea—Acitretin—psoriasis	0.000457	0.00186	CcSEcCtD
Primidone—Nausea—Fluocinolone Acetonide—psoriasis	0.000456	0.00186	CcSEcCtD
Primidone—Anaemia—Mycophenolate mofetil—psoriasis	0.000452	0.00184	CcSEcCtD
Primidone—Vertigo—Cyclosporine—psoriasis	0.000451	0.00183	CcSEcCtD
Primidone—Somnolence—Mycophenolic acid—psoriasis	0.00045	0.00183	CcSEcCtD
Primidone—Mental disorder—Hydrocortisone—psoriasis	0.000449	0.00183	CcSEcCtD
Primidone—Malnutrition—Hydrocortisone—psoriasis	0.000446	0.00181	CcSEcCtD
Primidone—Decreased appetite—Mycophenolic acid—psoriasis	0.00044	0.00179	CcSEcCtD
Primidone—Vertigo—Mycophenolate mofetil—psoriasis	0.00044	0.00179	CcSEcCtD
Primidone—Gastrointestinal disorder—Mycophenolic acid—psoriasis	0.000437	0.00178	CcSEcCtD
Primidone—Fatigue—Mycophenolic acid—psoriasis	0.000436	0.00178	CcSEcCtD
Primidone—Asthenia—Hydroxyurea—psoriasis	0.000434	0.00176	CcSEcCtD
Primidone—Ataxia—Methotrexate—psoriasis	0.000433	0.00176	CcSEcCtD
Primidone—Arthralgia—Cyclosporine—psoriasis	0.000427	0.00174	CcSEcCtD
Primidone—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—psoriasis	0.000424	0.00173	CcSEcCtD
Primidone—Depression—Prednisone—psoriasis	0.000423	0.00172	CcSEcCtD
Primidone—Visual impairment—Betamethasone—psoriasis	0.000422	0.00172	CcSEcCtD
Primidone—Visual impairment—Dexamethasone—psoriasis	0.000422	0.00172	CcSEcCtD
Primidone—Arthralgia—Mycophenolate mofetil—psoriasis	0.000417	0.0017	CcSEcCtD
Primidone—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—psoriasis	0.000414	0.00168	CcSEcCtD
Primidone—Vertigo—Prednisolone—psoriasis	0.00041	0.00167	CcSEcCtD
Primidone—Eye disorder—Betamethasone—psoriasis	0.000409	0.00166	CcSEcCtD
Primidone—Eye disorder—Dexamethasone—psoriasis	0.000409	0.00166	CcSEcCtD
Primidone—Nervous system disorder—Cyclosporine—psoriasis	0.000402	0.00163	CcSEcCtD
Primidone—Vertigo—Hydrocortisone—psoriasis	0.000401	0.00163	CcSEcCtD
Primidone—Dizziness—Hydroxyurea—psoriasis	0.0004	0.00163	CcSEcCtD
Primidone—Skin disorder—Cyclosporine—psoriasis	0.000398	0.00162	CcSEcCtD
Primidone—CYP2B6—CYP2E1 reactions—CYP2S1—psoriasis	0.000393	0.065	CbGpPWpGaD
Primidone—Nervous system disorder—Mycophenolate mofetil—psoriasis	0.000392	0.00159	CcSEcCtD
Primidone—Anorexia—Cyclosporine—psoriasis	0.00039	0.00159	CcSEcCtD
Primidone—Skin disorder—Mycophenolate mofetil—psoriasis	0.000388	0.00158	CcSEcCtD
Primidone—Vomiting—Hydroxyurea—psoriasis	0.000384	0.00156	CcSEcCtD
Primidone—Rash—Hydroxyurea—psoriasis	0.000381	0.00155	CcSEcCtD
Primidone—Anorexia—Mycophenolate mofetil—psoriasis	0.000381	0.00155	CcSEcCtD
Primidone—Dermatitis—Hydroxyurea—psoriasis	0.000381	0.00155	CcSEcCtD
Primidone—Headache—Hydroxyurea—psoriasis	0.000379	0.00154	CcSEcCtD
Primidone—Vertigo—Triamcinolone—psoriasis	0.000377	0.00154	CcSEcCtD
Primidone—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—psoriasis	0.000377	0.00153	CcSEcCtD
Primidone—Connective tissue disorder—Prednisone—psoriasis	0.000375	0.00152	CcSEcCtD
Primidone—Musculoskeletal discomfort—Cyclosporine—psoriasis	0.000373	0.00152	CcSEcCtD
Primidone—Somnolence—Cyclosporine—psoriasis	0.000364	0.00148	CcSEcCtD
Primidone—Musculoskeletal discomfort—Mycophenolate mofetil—psoriasis	0.000364	0.00148	CcSEcCtD
Primidone—Asthenia—Mycophenolic acid—psoriasis	0.000363	0.00148	CcSEcCtD
Primidone—Nausea—Hydroxyurea—psoriasis	0.000359	0.00146	CcSEcCtD
Primidone—Nervous system disorder—Hydrocortisone—psoriasis	0.000357	0.00145	CcSEcCtD
Primidone—Eye disorder—Prednisone—psoriasis	0.000356	0.00145	CcSEcCtD
Primidone—Decreased appetite—Cyclosporine—psoriasis	0.000356	0.00145	CcSEcCtD
Primidone—Somnolence—Mycophenolate mofetil—psoriasis	0.000355	0.00145	CcSEcCtD
Primidone—Drowsiness—Methotrexate—psoriasis	0.000355	0.00144	CcSEcCtD
Primidone—Depression—Methotrexate—psoriasis	0.000354	0.00144	CcSEcCtD
Primidone—Gastrointestinal disorder—Cyclosporine—psoriasis	0.000354	0.00144	CcSEcCtD
Primidone—Skin disorder—Hydrocortisone—psoriasis	0.000353	0.00144	CcSEcCtD
Primidone—Fatigue—Cyclosporine—psoriasis	0.000353	0.00144	CcSEcCtD
Primidone—Decreased appetite—Mycophenolate mofetil—psoriasis	0.000347	0.00141	CcSEcCtD
Primidone—Anorexia—Hydrocortisone—psoriasis	0.000347	0.00141	CcSEcCtD
Primidone—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	0.000345	0.0014	CcSEcCtD
Primidone—Vertigo—Dexamethasone—psoriasis	0.000342	0.00139	CcSEcCtD
Primidone—Vertigo—Betamethasone—psoriasis	0.000342	0.00139	CcSEcCtD
Primidone—Dizziness—Mycophenolic acid—psoriasis	0.000335	0.00136	CcSEcCtD
Primidone—Mental disorder—Prednisone—psoriasis	0.000334	0.00136	CcSEcCtD
Primidone—CYP2C8—CYP2E1 reactions—CYP2S1—psoriasis	0.000333	0.055	CbGpPWpGaD
Primidone—Malnutrition—Prednisone—psoriasis	0.000332	0.00135	CcSEcCtD
Primidone—Musculoskeletal discomfort—Hydrocortisone—psoriasis	0.000332	0.00135	CcSEcCtD
Primidone—Agranulocytosis—Methotrexate—psoriasis	0.000331	0.00135	CcSEcCtD
Primidone—Vomiting—Mycophenolic acid—psoriasis	0.000322	0.00131	CcSEcCtD
Primidone—Rash—Mycophenolic acid—psoriasis	0.000319	0.0013	CcSEcCtD
Primidone—Dermatitis—Mycophenolic acid—psoriasis	0.000319	0.0013	CcSEcCtD
Primidone—Headache—Mycophenolic acid—psoriasis	0.000317	0.00129	CcSEcCtD
Primidone—Decreased appetite—Hydrocortisone—psoriasis	0.000316	0.00129	CcSEcCtD
Primidone—Gastrointestinal disorder—Hydrocortisone—psoriasis	0.000314	0.00128	CcSEcCtD
Primidone—Fatigue—Hydrocortisone—psoriasis	0.000314	0.00128	CcSEcCtD
Primidone—Musculoskeletal discomfort—Triamcinolone—psoriasis	0.000312	0.00127	CcSEcCtD
Primidone—Visual impairment—Methotrexate—psoriasis	0.000307	0.00125	CcSEcCtD
Primidone—Anaemia—Prednisone—psoriasis	0.000307	0.00125	CcSEcCtD
Primidone—Nervous system disorder—Betamethasone—psoriasis	0.000305	0.00124	CcSEcCtD
Primidone—Nervous system disorder—Dexamethasone—psoriasis	0.000305	0.00124	CcSEcCtD
Primidone—Nausea—Mycophenolic acid—psoriasis	0.000301	0.00122	CcSEcCtD
Primidone—Vertigo—Prednisone—psoriasis	0.000298	0.00121	CcSEcCtD
Primidone—Eye disorder—Methotrexate—psoriasis	0.000298	0.00121	CcSEcCtD
Primidone—CYP2C19—CYP2E1 reactions—CYP2S1—psoriasis	0.000297	0.0491	CbGpPWpGaD
Primidone—Anorexia—Betamethasone—psoriasis	0.000296	0.00121	CcSEcCtD
Primidone—Anorexia—Dexamethasone—psoriasis	0.000296	0.00121	CcSEcCtD
Primidone—Fatigue—Triamcinolone—psoriasis	0.000295	0.0012	CcSEcCtD
Primidone—Asthenia—Cyclosporine—psoriasis	0.000294	0.0012	CcSEcCtD
Primidone—Asthenia—Mycophenolate mofetil—psoriasis	0.000287	0.00117	CcSEcCtD
Primidone—Musculoskeletal discomfort—Dexamethasone—psoriasis	0.000283	0.00115	CcSEcCtD
Primidone—Musculoskeletal discomfort—Betamethasone—psoriasis	0.000283	0.00115	CcSEcCtD
Primidone—Arthralgia—Prednisone—psoriasis	0.000282	0.00115	CcSEcCtD
Primidone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	0.000281	0.00114	CcSEcCtD
Primidone—Mental disorder—Methotrexate—psoriasis	0.000279	0.00114	CcSEcCtD
Primidone—Malnutrition—Methotrexate—psoriasis	0.000277	0.00113	CcSEcCtD
Primidone—CYP2C9—CYP2E1 reactions—CYP2S1—psoriasis	0.000271	0.0448	CbGpPWpGaD
Primidone—Dizziness—Cyclosporine—psoriasis	0.000271	0.0011	CcSEcCtD
Primidone—Decreased appetite—Dexamethasone—psoriasis	0.00027	0.0011	CcSEcCtD
Primidone—Decreased appetite—Betamethasone—psoriasis	0.00027	0.0011	CcSEcCtD
Primidone—Gastrointestinal disorder—Betamethasone—psoriasis	0.000268	0.00109	CcSEcCtD
Primidone—Gastrointestinal disorder—Dexamethasone—psoriasis	0.000268	0.00109	CcSEcCtD
Primidone—Fatigue—Dexamethasone—psoriasis	0.000268	0.00109	CcSEcCtD
Primidone—Fatigue—Betamethasone—psoriasis	0.000268	0.00109	CcSEcCtD
Primidone—Nervous system disorder—Prednisone—psoriasis	0.000266	0.00108	CcSEcCtD
Primidone—Dizziness—Mycophenolate mofetil—psoriasis	0.000264	0.00108	CcSEcCtD
Primidone—Skin disorder—Prednisone—psoriasis	0.000263	0.00107	CcSEcCtD
Primidone—Asthenia—Hydrocortisone—psoriasis	0.000261	0.00106	CcSEcCtD
Primidone—Vomiting—Cyclosporine—psoriasis	0.00026	0.00106	CcSEcCtD
Primidone—Rash—Cyclosporine—psoriasis	0.000258	0.00105	CcSEcCtD
Primidone—Anorexia—Prednisone—psoriasis	0.000258	0.00105	CcSEcCtD
Primidone—Dermatitis—Cyclosporine—psoriasis	0.000258	0.00105	CcSEcCtD
Primidone—Headache—Cyclosporine—psoriasis	0.000257	0.00104	CcSEcCtD
Primidone—Anaemia—Methotrexate—psoriasis	0.000256	0.00104	CcSEcCtD
Primidone—Vomiting—Mycophenolate mofetil—psoriasis	0.000254	0.00103	CcSEcCtD
Primidone—Rash—Mycophenolate mofetil—psoriasis	0.000252	0.00103	CcSEcCtD
Primidone—Dermatitis—Mycophenolate mofetil—psoriasis	0.000252	0.00102	CcSEcCtD
Primidone—Headache—Mycophenolate mofetil—psoriasis	0.00025	0.00102	CcSEcCtD
Primidone—Vertigo—Methotrexate—psoriasis	0.000249	0.00101	CcSEcCtD
Primidone—Musculoskeletal discomfort—Prednisone—psoriasis	0.000247	0.001	CcSEcCtD
Primidone—Dizziness—Prednisolone—psoriasis	0.000246	0.001	CcSEcCtD
Primidone—Asthenia—Triamcinolone—psoriasis	0.000246	0.001	CcSEcCtD
Primidone—CYP2B6—Xenobiotics—CYP2S1—psoriasis	0.000244	0.0403	CbGpPWpGaD
Primidone—Nausea—Cyclosporine—psoriasis	0.000243	0.00099	CcSEcCtD
Primidone—Dizziness—Hydrocortisone—psoriasis	0.000241	0.000979	CcSEcCtD
Primidone—Nausea—Mycophenolate mofetil—psoriasis	0.000237	0.000966	CcSEcCtD
Primidone—Arthralgia—Methotrexate—psoriasis	0.000236	0.000961	CcSEcCtD
Primidone—Decreased appetite—Prednisone—psoriasis	0.000235	0.000958	CcSEcCtD
Primidone—Rash—Prednisolone—psoriasis	0.000235	0.000956	CcSEcCtD
Primidone—Dermatitis—Prednisolone—psoriasis	0.000235	0.000955	CcSEcCtD
Primidone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	0.000234	0.000954	CcSEcCtD
Primidone—Fatigue—Prednisone—psoriasis	0.000233	0.00095	CcSEcCtD
Primidone—Headache—Prednisolone—psoriasis	0.000233	0.00095	CcSEcCtD
Primidone—Vomiting—Hydrocortisone—psoriasis	0.000231	0.000942	CcSEcCtD
Primidone—Rash—Hydrocortisone—psoriasis	0.000229	0.000934	CcSEcCtD
Primidone—Dermatitis—Hydrocortisone—psoriasis	0.000229	0.000933	CcSEcCtD
Primidone—Headache—Hydrocortisone—psoriasis	0.000228	0.000928	CcSEcCtD
Primidone—Dizziness—Triamcinolone—psoriasis	0.000227	0.000922	CcSEcCtD
Primidone—Asthenia—Betamethasone—psoriasis	0.000223	0.000908	CcSEcCtD
Primidone—Asthenia—Dexamethasone—psoriasis	0.000223	0.000908	CcSEcCtD
Primidone—Nervous system disorder—Methotrexate—psoriasis	0.000222	0.000903	CcSEcCtD
Primidone—Nausea—Prednisolone—psoriasis	0.000221	0.000901	CcSEcCtD
Primidone—Skin disorder—Methotrexate—psoriasis	0.00022	0.000895	CcSEcCtD
Primidone—Vomiting—Triamcinolone—psoriasis	0.000218	0.000887	CcSEcCtD
Primidone—Nausea—Hydrocortisone—psoriasis	0.000216	0.00088	CcSEcCtD
Primidone—Rash—Triamcinolone—psoriasis	0.000216	0.000879	CcSEcCtD
Primidone—Dermatitis—Triamcinolone—psoriasis	0.000216	0.000878	CcSEcCtD
Primidone—Anorexia—Methotrexate—psoriasis	0.000216	0.000878	CcSEcCtD
Primidone—Headache—Triamcinolone—psoriasis	0.000215	0.000874	CcSEcCtD
Primidone—CYP2C8—Xenobiotics—CYP2S1—psoriasis	0.000206	0.0341	CbGpPWpGaD
Primidone—Musculoskeletal discomfort—Methotrexate—psoriasis	0.000206	0.000839	CcSEcCtD
Primidone—Dizziness—Dexamethasone—psoriasis	0.000206	0.000837	CcSEcCtD
Primidone—Dizziness—Betamethasone—psoriasis	0.000206	0.000837	CcSEcCtD
Primidone—Nausea—Triamcinolone—psoriasis	0.000204	0.000828	CcSEcCtD
Primidone—Somnolence—Methotrexate—psoriasis	0.000201	0.000819	CcSEcCtD
Primidone—Vomiting—Betamethasone—psoriasis	0.000198	0.000805	CcSEcCtD
Primidone—Vomiting—Dexamethasone—psoriasis	0.000198	0.000805	CcSEcCtD
Primidone—Decreased appetite—Methotrexate—psoriasis	0.000197	0.000801	CcSEcCtD
Primidone—Rash—Betamethasone—psoriasis	0.000196	0.000798	CcSEcCtD
Primidone—Rash—Dexamethasone—psoriasis	0.000196	0.000798	CcSEcCtD
Primidone—Dermatitis—Dexamethasone—psoriasis	0.000196	0.000797	CcSEcCtD
Primidone—Dermatitis—Betamethasone—psoriasis	0.000196	0.000797	CcSEcCtD
Primidone—Gastrointestinal disorder—Methotrexate—psoriasis	0.000195	0.000795	CcSEcCtD
Primidone—Fatigue—Methotrexate—psoriasis	0.000195	0.000794	CcSEcCtD
Primidone—Headache—Dexamethasone—psoriasis	0.000195	0.000793	CcSEcCtD
Primidone—Headache—Betamethasone—psoriasis	0.000195	0.000793	CcSEcCtD
Primidone—Asthenia—Prednisone—psoriasis	0.000194	0.000791	CcSEcCtD
Primidone—Nausea—Dexamethasone—psoriasis	0.000185	0.000752	CcSEcCtD
Primidone—Nausea—Betamethasone—psoriasis	0.000185	0.000752	CcSEcCtD
Primidone—CYP2C19—Xenobiotics—CYP2S1—psoriasis	0.000184	0.0304	CbGpPWpGaD
Primidone—Dizziness—Prednisone—psoriasis	0.000179	0.000729	CcSEcCtD
Primidone—Vomiting—Prednisone—psoriasis	0.000172	0.000701	CcSEcCtD
Primidone—Rash—Prednisone—psoriasis	0.000171	0.000695	CcSEcCtD
Primidone—Dermatitis—Prednisone—psoriasis	0.000171	0.000694	CcSEcCtD
Primidone—Headache—Prednisone—psoriasis	0.00017	0.00069	CcSEcCtD
Primidone—CYP2C9—Xenobiotics—CYP2S1—psoriasis	0.000168	0.0278	CbGpPWpGaD
Primidone—Asthenia—Methotrexate—psoriasis	0.000162	0.000661	CcSEcCtD
Primidone—Nausea—Prednisone—psoriasis	0.000161	0.000655	CcSEcCtD
Primidone—Dizziness—Methotrexate—psoriasis	0.00015	0.000609	CcSEcCtD
Primidone—Vomiting—Methotrexate—psoriasis	0.000144	0.000586	CcSEcCtD
Primidone—CYP1A2—Xenobiotics—CYP2S1—psoriasis	0.000144	0.0237	CbGpPWpGaD
Primidone—Rash—Methotrexate—psoriasis	0.000143	0.000581	CcSEcCtD
Primidone—Dermatitis—Methotrexate—psoriasis	0.000143	0.00058	CcSEcCtD
Primidone—Headache—Methotrexate—psoriasis	0.000142	0.000577	CcSEcCtD
Primidone—Nausea—Methotrexate—psoriasis	0.000134	0.000547	CcSEcCtD
Primidone—CYP3A4—Xenobiotics—CYP2S1—psoriasis	0.000111	0.0183	CbGpPWpGaD
Primidone—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000101	0.0167	CbGpPWpGaD
Primidone—CYP2B6—Oxidation by Cytochrome P450—CYP2S1—psoriasis	9.99e-05	0.0165	CbGpPWpGaD
Primidone—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	8.57e-05	0.0142	CbGpPWpGaD
Primidone—CYP2C8—Oxidation by Cytochrome P450—CYP2S1—psoriasis	8.46e-05	0.014	CbGpPWpGaD
Primidone—CYP2B6—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	8.21e-05	0.0136	CbGpPWpGaD
Primidone—CHRNA7—SIDS Susceptibility Pathways—RUNX3—psoriasis	7.89e-05	0.013	CbGpPWpGaD
Primidone—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	7.65e-05	0.0126	CbGpPWpGaD
Primidone—CYP2C19—Oxidation by Cytochrome P450—CYP2S1—psoriasis	7.55e-05	0.0125	CbGpPWpGaD
Primidone—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	6.98e-05	0.0115	CbGpPWpGaD
Primidone—CYP2C8—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	6.95e-05	0.0115	CbGpPWpGaD
Primidone—CYP2C9—Oxidation by Cytochrome P450—CYP2S1—psoriasis	6.89e-05	0.0114	CbGpPWpGaD
Primidone—GABRA6—Orphan transporters—CARM1—psoriasis	6.49e-05	0.0107	CbGpPWpGaD
Primidone—CHRNA4—SIDS Susceptibility Pathways—RUNX3—psoriasis	6.43e-05	0.0106	CbGpPWpGaD
Primidone—GABRA4—Orphan transporters—CARM1—psoriasis	6.41e-05	0.0106	CbGpPWpGaD
Primidone—CHRNA7—SIDS Susceptibility Pathways—IL13—psoriasis	6.23e-05	0.0103	CbGpPWpGaD
Primidone—CYP2C19—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	6.2e-05	0.0102	CbGpPWpGaD
Primidone—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	5.96e-05	0.00985	CbGpPWpGaD
Primidone—CYP1A2—Oxidation by Cytochrome P450—CYP2S1—psoriasis	5.88e-05	0.00972	CbGpPWpGaD
Primidone—GABRB2—Orphan transporters—CARM1—psoriasis	5.86e-05	0.00968	CbGpPWpGaD
Primidone—GABRA5—Orphan transporters—CARM1—psoriasis	5.69e-05	0.0094	CbGpPWpGaD
Primidone—CYP2C9—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	5.66e-05	0.00934	CbGpPWpGaD
Primidone—GABRA3—Orphan transporters—CARM1—psoriasis	5.59e-05	0.00923	CbGpPWpGaD
Primidone—GABRA2—Orphan transporters—CARM1—psoriasis	5.49e-05	0.00907	CbGpPWpGaD
Primidone—GABRG2—Orphan transporters—CARM1—psoriasis	5.36e-05	0.00885	CbGpPWpGaD
Primidone—CHRNA4—SIDS Susceptibility Pathways—IL13—psoriasis	5.08e-05	0.00839	CbGpPWpGaD
Primidone—CYP1A2—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	4.83e-05	0.00798	CbGpPWpGaD
Primidone—GABRA1—Orphan transporters—CARM1—psoriasis	4.68e-05	0.00774	CbGpPWpGaD
Primidone—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	4.65e-05	0.00768	CbGpPWpGaD
Primidone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	4.6e-05	0.0076	CbGpPWpGaD
Primidone—CYP3A4—Oxidation by Cytochrome P450—CYP2S1—psoriasis	4.54e-05	0.0075	CbGpPWpGaD
Primidone—CYP2B6—Biological oxidations—CYP2S1—psoriasis	4.36e-05	0.0072	CbGpPWpGaD
Primidone—CYP2B6—Metapathway biotransformation—CYP2S1—psoriasis	4.3e-05	0.0071	CbGpPWpGaD
Primidone—GABRA1—SIDS Susceptibility Pathways—RUNX3—psoriasis	3.98e-05	0.00658	CbGpPWpGaD
Primidone—CHRNA7—SIDS Susceptibility Pathways—IL10—psoriasis	3.9e-05	0.00644	CbGpPWpGaD
Primidone—CYP3A4—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	3.73e-05	0.00616	CbGpPWpGaD
Primidone—CYP2C8—Biological oxidations—CYP2S1—psoriasis	3.69e-05	0.0061	CbGpPWpGaD
Primidone—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	3.68e-05	0.00608	CbGpPWpGaD
Primidone—CYP2C8—Metapathway biotransformation—CYP2S1—psoriasis	3.64e-05	0.00601	CbGpPWpGaD
Primidone—CYP2C19—Biological oxidations—CYP2S1—psoriasis	3.3e-05	0.00544	CbGpPWpGaD
Primidone—CYP2C19—Metapathway biotransformation—CYP2S1—psoriasis	3.25e-05	0.00537	CbGpPWpGaD
Primidone—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	3.24e-05	0.00536	CbGpPWpGaD
Primidone—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	3.21e-05	0.00529	CbGpPWpGaD
Primidone—CYP2C19—Melatonin metabolism and effects—APOE—psoriasis	3.2e-05	0.00528	CbGpPWpGaD
Primidone—CHRNA4—SIDS Susceptibility Pathways—IL10—psoriasis	3.18e-05	0.00525	CbGpPWpGaD
Primidone—GABRA1—SIDS Susceptibility Pathways—IL13—psoriasis	3.14e-05	0.00519	CbGpPWpGaD
Primidone—CYP2C9—Biological oxidations—CYP2S1—psoriasis	3e-05	0.00496	CbGpPWpGaD
Primidone—CYP2C9—Metapathway biotransformation—CYP2S1—psoriasis	2.96e-05	0.0049	CbGpPWpGaD
Primidone—CYP1A2—Estrogen Receptor Pathway—JUN—psoriasis	2.92e-05	0.00483	CbGpPWpGaD
Primidone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriasis	2.86e-05	0.00473	CbGpPWpGaD
Primidone—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	2.74e-05	0.00452	CbGpPWpGaD
Primidone—GRIA2—BDNF signaling pathway—NFKBIA—psoriasis	2.68e-05	0.00442	CbGpPWpGaD
Primidone—CYP1A2—Biological oxidations—CYP2S1—psoriasis	2.57e-05	0.00424	CbGpPWpGaD
Primidone—CYP1A2—Metapathway biotransformation—CYP2S1—psoriasis	2.53e-05	0.00418	CbGpPWpGaD
Primidone—CYP1A2—Estrogen Receptor Pathway—STAT3—psoriasis	2.53e-05	0.00418	CbGpPWpGaD
Primidone—CYP1A2—Melatonin metabolism and effects—APOE—psoriasis	2.49e-05	0.00411	CbGpPWpGaD
Primidone—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	2.23e-05	0.00369	CbGpPWpGaD
Primidone—CYP1A2—Tryptophan metabolism—CAT—psoriasis	2.22e-05	0.00366	CbGpPWpGaD
Primidone—CHRNA7—SIDS Susceptibility Pathways—CXCL8—psoriasis	2.13e-05	0.00352	CbGpPWpGaD
Primidone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	2.11e-05	0.00349	CbGpPWpGaD
Primidone—CYP3A4—Biological oxidations—CYP2S1—psoriasis	1.98e-05	0.00327	CbGpPWpGaD
Primidone—CHRNA7—SIDS Susceptibility Pathways—JUN—psoriasis	1.98e-05	0.00327	CbGpPWpGaD
Primidone—GABRA1—SIDS Susceptibility Pathways—IL10—psoriasis	1.97e-05	0.00325	CbGpPWpGaD
Primidone—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	1.95e-05	0.00323	CbGpPWpGaD
Primidone—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	1.91e-05	0.00315	CbGpPWpGaD
Primidone—CHRNA7—SIDS Susceptibility Pathways—NFKB1—psoriasis	1.91e-05	0.00315	CbGpPWpGaD
Primidone—CYP2C19—Melatonin metabolism and effects—NFKB1—psoriasis	1.9e-05	0.00314	CbGpPWpGaD
Primidone—GRIA2—BDNF signaling pathway—JUN—psoriasis	1.78e-05	0.00293	CbGpPWpGaD
Primidone—CHRNA4—SIDS Susceptibility Pathways—CXCL8—psoriasis	1.74e-05	0.00287	CbGpPWpGaD
Primidone—CHRNA7—SIDS Susceptibility Pathways—VEGFA—psoriasis	1.73e-05	0.00286	CbGpPWpGaD
Primidone—CYP3A4—Tryptophan metabolism—CAT—psoriasis	1.71e-05	0.00282	CbGpPWpGaD
Primidone—GRIA2—BDNF signaling pathway—NFKB1—psoriasis	1.71e-05	0.00282	CbGpPWpGaD
Primidone—GABRA6—Transmembrane transport of small molecules—CP—psoriasis	1.66e-05	0.00274	CbGpPWpGaD
Primidone—GABRA4—Transmembrane transport of small molecules—CP—psoriasis	1.64e-05	0.00271	CbGpPWpGaD
Primidone—CHRNA4—SIDS Susceptibility Pathways—JUN—psoriasis	1.61e-05	0.00267	CbGpPWpGaD
Primidone—GABRA6—Transmembrane transport of small molecules—CARM1—psoriasis	1.58e-05	0.00262	CbGpPWpGaD
Primidone—GABRA4—Transmembrane transport of small molecules—CARM1—psoriasis	1.56e-05	0.00258	CbGpPWpGaD
Primidone—CHRNA4—SIDS Susceptibility Pathways—NFKB1—psoriasis	1.55e-05	0.00257	CbGpPWpGaD
Primidone—GRIA2—BDNF signaling pathway—STAT3—psoriasis	1.54e-05	0.00254	CbGpPWpGaD
Primidone—GABRB2—Transmembrane transport of small molecules—CP—psoriasis	1.5e-05	0.00248	CbGpPWpGaD
Primidone—CHRNA7—SIDS Susceptibility Pathways—TNF—psoriasis	1.48e-05	0.00245	CbGpPWpGaD
Primidone—CYP1A2—Melatonin metabolism and effects—NFKB1—psoriasis	1.48e-05	0.00245	CbGpPWpGaD
Primidone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	1.47e-05	0.00243	CbGpPWpGaD
Primidone—GABRA5—Transmembrane transport of small molecules—CP—psoriasis	1.46e-05	0.00241	CbGpPWpGaD
Primidone—GABRA3—Transmembrane transport of small molecules—CP—psoriasis	1.43e-05	0.00236	CbGpPWpGaD
Primidone—GABRB2—Transmembrane transport of small molecules—CARM1—psoriasis	1.43e-05	0.00236	CbGpPWpGaD
Primidone—CHRNA4—SIDS Susceptibility Pathways—VEGFA—psoriasis	1.41e-05	0.00233	CbGpPWpGaD
Primidone—GABRA2—Transmembrane transport of small molecules—CP—psoriasis	1.41e-05	0.00232	CbGpPWpGaD
Primidone—GABRA5—Transmembrane transport of small molecules—CARM1—psoriasis	1.39e-05	0.0023	CbGpPWpGaD
Primidone—GABRG2—Transmembrane transport of small molecules—CP—psoriasis	1.37e-05	0.00227	CbGpPWpGaD
Primidone—GABRA3—Transmembrane transport of small molecules—CARM1—psoriasis	1.36e-05	0.00225	CbGpPWpGaD
Primidone—GABRA2—Transmembrane transport of small molecules—CARM1—psoriasis	1.34e-05	0.00222	CbGpPWpGaD
Primidone—GABRG2—Transmembrane transport of small molecules—CARM1—psoriasis	1.31e-05	0.00216	CbGpPWpGaD
Primidone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	1.23e-05	0.00203	CbGpPWpGaD
Primidone—CHRNA4—SIDS Susceptibility Pathways—TNF—psoriasis	1.21e-05	0.002	CbGpPWpGaD
Primidone—GABRA1—Transmembrane transport of small molecules—CP—psoriasis	1.2e-05	0.00198	CbGpPWpGaD
Primidone—CHRNA7—SIDS Susceptibility Pathways—IL6—psoriasis	1.2e-05	0.00198	CbGpPWpGaD
Primidone—GABRA1—Transmembrane transport of small molecules—CARM1—psoriasis	1.14e-05	0.00189	CbGpPWpGaD
Primidone—GABRA1—SIDS Susceptibility Pathways—CXCL8—psoriasis	1.08e-05	0.00178	CbGpPWpGaD
Primidone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	1.06e-05	0.00176	CbGpPWpGaD
Primidone—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	1.02e-05	0.00169	CbGpPWpGaD
Primidone—GABRA1—SIDS Susceptibility Pathways—JUN—psoriasis	1e-05	0.00165	CbGpPWpGaD
Primidone—CHRNA4—SIDS Susceptibility Pathways—IL6—psoriasis	9.76e-06	0.00161	CbGpPWpGaD
Primidone—GABRA1—SIDS Susceptibility Pathways—NFKB1—psoriasis	9.62e-06	0.00159	CbGpPWpGaD
Primidone—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	9.29e-06	0.00153	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—NDUFA5—psoriasis	8.77e-06	0.00145	CbGpPWpGaD
Primidone—GABRA1—SIDS Susceptibility Pathways—VEGFA—psoriasis	8.73e-06	0.00144	CbGpPWpGaD
Primidone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	7.96e-06	0.00132	CbGpPWpGaD
Primidone—CYP1A2—Aryl Hydrocarbon Receptor—TNF—psoriasis	7.96e-06	0.00132	CbGpPWpGaD
Primidone—GABRA1—SIDS Susceptibility Pathways—TNF—psoriasis	7.49e-06	0.00124	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—CYP2S1—psoriasis	7.46e-06	0.00123	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—NDUFA5—psoriasis	7.43e-06	0.00123	CbGpPWpGaD
Primidone—CYP2C8—Metabolism of lipids and lipoproteins—CARM1—psoriasis	6.92e-06	0.00114	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—NDUFA5—psoriasis	6.63e-06	0.00109	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—CYP2S1—psoriasis	6.31e-06	0.00104	CbGpPWpGaD
Primidone—CYP2C19—Metabolism of lipids and lipoproteins—CARM1—psoriasis	6.18e-06	0.00102	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—NDUFA5—psoriasis	6.04e-06	0.000998	CbGpPWpGaD
Primidone—GABRA1—SIDS Susceptibility Pathways—IL6—psoriasis	6.04e-06	0.000998	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—CYP2S1—psoriasis	5.64e-06	0.000931	CbGpPWpGaD
Primidone—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—psoriasis	5.63e-06	0.000931	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—NDUFA5—psoriasis	5.16e-06	0.000853	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—CYP2S1—psoriasis	5.14e-06	0.000849	CbGpPWpGaD
Primidone—CYP1A2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	4.82e-06	0.000795	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—CYP2S1—psoriasis	4.39e-06	0.000725	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—NDUFA5—psoriasis	3.99e-06	0.000658	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—CARM1—psoriasis	3.64e-06	0.000602	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—CYP2S1—psoriasis	3.39e-06	0.00056	CbGpPWpGaD
Primidone—CYP2C8—Metabolism of lipids and lipoproteins—APOE—psoriasis	3.31e-06	0.000547	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—CARM1—psoriasis	3.08e-06	0.000509	CbGpPWpGaD
Primidone—CYP2C19—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.95e-06	0.000488	CbGpPWpGaD
Primidone—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.88e-06	0.000476	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—CARM1—psoriasis	2.75e-06	0.000455	CbGpPWpGaD
Primidone—CYP2C9—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.69e-06	0.000445	CbGpPWpGaD
Primidone—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.57e-06	0.000425	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—CARM1—psoriasis	2.51e-06	0.000415	CbGpPWpGaD
Primidone—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.35e-06	0.000387	CbGpPWpGaD
Primidone—CYP1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.3e-06	0.00038	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—CAT—psoriasis	2.24e-06	0.00037	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—CARM1—psoriasis	2.14e-06	0.000354	CbGpPWpGaD
Primidone—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2e-06	0.000331	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—CAT—psoriasis	1.9e-06	0.000313	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—APOE—psoriasis	1.74e-06	0.000288	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—CAT—psoriasis	1.69e-06	0.00028	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—CARM1—psoriasis	1.66e-06	0.000273	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—CAT—psoriasis	1.54e-06	0.000255	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—PPARG—psoriasis	1.52e-06	0.00025	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—APOE—psoriasis	1.47e-06	0.000243	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—CAT—psoriasis	1.32e-06	0.000218	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—APOE—psoriasis	1.32e-06	0.000217	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—PPARG—psoriasis	1.28e-06	0.000212	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—APOE—psoriasis	1.2e-06	0.000198	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—PPARG—psoriasis	1.15e-06	0.000189	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—PPARG—psoriasis	1.04e-06	0.000173	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—APOE—psoriasis	1.02e-06	0.000169	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—CAT—psoriasis	1.02e-06	0.000168	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—PPARG—psoriasis	8.93e-07	0.000147	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—APOE—psoriasis	7.91e-07	0.000131	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—PPARG—psoriasis	6.89e-07	0.000114	CbGpPWpGaD
